(Q40216395)

18 September 2017

1 reference

title

Vanadium and manic depressive psychosis (English)

1 reference

18 September 2017

G J Naylor

1

1 reference

18 September 2017

publication date

1 January 1984

1 reference

18 September 2017

1 reference

18 September 2017

volume

3

1 reference

18 September 2017

issue

1-2

1 reference

18 September 2017

page(s)

79-85

1 reference

Abnormality of the blood-cerebrospinal fluid barrier of patients suffering from a depressive illness

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F026010608400300206

Diminished membrane transport in manic-depressive psychosis and recurrent depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010608400300206

Methylene blue. A possible treatment for manic depressive psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010608400300206

Possible explanation for therapeutic action of lithium, and a possible substitute (methylene-blue)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010608400300206

Catalysis of the reduction of vanadate by psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010608400300206

A Comparative Trial of Imipramine and Chlorpromazine in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010608400300206

ABNORMAL TRACE METALS IN MAN--VANADIUM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010608400300206

Reduction of vanadate to vanadyl by methylene-blue, imipramine, and chlorpromazine in absence of NADH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026010608400300206

10.1177/026010608400300206

21 January 2018

Identifiers

DOI

0 references

1 reference